Severe acne can be horrifically debilitating. It leaves sufferers drained of confidence, sometimes even unwilling to leave the house. Case numbers have been growing globally for the past three decades ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — A rapid improvement in severe acne was observed in patients treated with 12 weeks of trifarotene and ...

In this digital age of flawless, perfect, poreless skin, dealing with adult acne can be incredibly isolating. Two skinfluencers and a photographer open up about their acne journeys, the pressure for ...

BRISBANE, Calif.--(BUSINESS WIRE)--Ninety percent of moderate to severe acne sufferers said having acne-free skin would dramatically change the way they live their life, according to a new survey ...

Please provide your email address to receive an email when new articles are posted on . A combination of microencapsulated benzoyl peroxide and microencapsulated tretinoin significantly improved ...

Isotretinoin, commonly referred to as Accutane, is the only approved medical treatment capable of inducing long-term remission of severe acne. Although highly effective, some individuals experience ...

Acne vulgaris Researchers examined the relationship between dairy and acne severity and frequency. A significantly lower frequency of acne, as well as lower rates of severe acne, has been reported ...

Although many topical or systemic antibiotics exist to treat acne vulgaris, the common inflammatory skin disease is not fully treatable. A new article published in The Journal of Clinical and ...

Whenever you notice a new pregnancy symptom, you're probably desperate to decode its hidden meaning. Are you having a boy ...

SAN DIEGO, June 10, 2020 /PRNewswire/ -- Dermata Therapeutics' lead clinical candidate, DMT310, produced statistically significant results at week 4, 8 and 12 for all its primary and secondary ...

Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...